NCT01290367 - Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2015

Conditions

Degenerative Disc Disease

Interventions

BIOLOGICAL

Single Dose MPCs Injection

Injection of Low Dose MPCs with Hyaluronic Acid into the degenerated lumbar disc's nucleus pulposus.

PROCEDURE

Single injection of saline solution

Intradiscal control injection with saline solution

PROCEDURE

Single injection of hyaluronic acid

Intradiscal control injection with hyaluronic acid

BIOLOGICAL

Single Dose MPCs Injection

Injection of HighDose MPCs with Hyaluronic Acid into the degenerated lumbar disc's nucleus pulposus.

Trial Locations (14)

3168

Monash Medical Center, Clayton

23235

Virginia Spine Research Institute, Inc., Richmond

25301

The Center for Pain Relief, Inc., Charleston

28204

Carolina Neurosurgery and Spine Associates, Charlotte

30329

Emory University School of Medicine, Atlanta

77469

Richmond Bone and Joint Clinic, Memorial Hermann Medical Group, Richmond

78731

Central Texas Spine Institute, Austin

80111

Denver Spine, Denver

80538

Rocky Mountain Associates in Orthopedic Medicine, P.C., Loveland

85258

Arizona Pain Specialists, Scottsdale

90403

The Spine Institute, Santa Monica

94598

IPM Medical Group, Inc., Walnut Creek

95816

UC Davis Spine Center, Sacramento

98026

Washington Center for Pain Management, Edmonds